
درهآور
دارویی ره آورد تامین
Adjusted Price Chart of درهآور and درهآور Signal Trend
Traders' comments on price درهآور
Who made the most profit from درهآور?
Signals of درهآور
Filter
Signal Type
Trader Type
Time Frame
نوع پیام

نرم افزار تحلیل گر بورس - دایموند
#Group sales report #medicine In June 1404, pharmaceutical companies sold 17467 billion tomans, which increased by 40 % compared to the same year last year. 💵 Export sales of 204 billion tomans, which increased by 5 % compared to the same year. #Dezagress Company registered the highest export with 124 billion USD. ✅ #Broadcasting Company with the highest sales of 3503 billion USD had the highest sales. The following companies recorded the highest growth rate compared to the same year. #Dafra 148% #Dalk 137%🔥 #102% Long #Caspian 97% #87% medicine #Damidid 82%🔥 #82%Demeravi #75% Broadcast #72% Daller #66% #60% Dignity #59% #53% decay #Decoration 52%🔥 #48% Deanko #47%🔥 #Depars 46%🔥 #46% Dukimi #44% dendina #41% difficulty #Deller 29% #29% detection #27% Dabor #Defense 25% #21% biiotic #19% Hijra #Dasou 17% #16% late #2% 📅 Last Update: 1404/04/20 Support the capital market by submitting this report in groups and stock markets; 🇮🇷@dndir
BFM box. Q. A. B. Sabbagstetant and Gastamine bought 0.687 million shares on 10/04/10 and now accounted for 1.569 % of the stock in its portfolio.

صندوق سرمایه گذاری بخشی صنایع مفید -دارونو
The Investment Fund for useful industries -083 million shares bought the rear -storeed share on 24/03/24 and currently holds 1.308 % of the relevant shares in its equity portfolio.

صندوق سرمایه گذاری بخشی صنایع مفید -دارونو
The Investment Fund for useful industries -083 million shares purchased 1.083 million shares on 14/03/21 and currently holds 1.308 % of the stock in its equity portfolio.

صندوق سرمایه گذاری قابل معامله بخشی کیان
The Kian Trading Investment Fund has sold 0.023 million shares on 14/03/19 and currently holds 1.02 % of the stock in its portfolio.

صندوق سرمایه گذاری قابل معامله بخشی کیان
The Kian Trading Investment Fund has sold 0.358 million shares on 14/03/18 and currently holds 1.021 % of the stock in its equity portfolio.

صندوق سرمایه گذاری قابل معامله بخشی کیان
The Kian Trading Investment Fund has sold 0.528 million shares on 14/03/14 and currently holds 1.035 % of the stock in its equity portfolio.

صندوق سرمایه گذاری قابل معامله بخشی کیان
The Kian Trading Investment Fund sold 0.528 million shares on 14/03/13 and currently holds 1.035 % of the stock in its equity portfolio.

حمید کوشکی(تحلیل کاربردی)
🔎 Weight loss of Tipico and Dafara; Buy Designing 💊 🗓 Review #Pharmaceutical Department Portfolio #Darreno to May 1404 انی The land has bought 78 billion tomans in the last month and has sold 64 billion tomans. 🟢 Most of the shopping: Dezagress - Valley The Most Best Sales: Tipico - Dafara The stock weight increased by 1.1 percent compared to the previous month and the deposit weight decreased by 5.2 percent compared to the previous month. 🌐 Finder

صندوق سرمایه گذاری قابل معامله بخشی کیان
The Kian Trading Investment Fund has sold 0.203 million shares on 10/03/10 and currently accounts for 1.054 % of the vallear shares in its joint portfolio.
افزایش سرمایه درهآور
تاریخ | نوع افزایش سرمایه | درصد افزایش سرمایه |
---|---|---|
1403/12/07 | سود انباشته,مازاد تجدید ارزیابی | 970% |
1400/02/08 | صرف سهام | 25% |
تقسیم سود درهآور
تاریخ | مقدار سود | درصد تقسیم سود |
---|---|---|
1404/02/16 | 1010 | 79.28% |
1403/02/18 | 8700 | 69.94% |
1402/03/28 | 9186 | 94.66% |
1401/04/01 | 3710 | 92.33% |
1400/03/22 | 2407 | 92.43% |
مجامع درهآور
تاریخ | نوع مجامع |
---|---|
1404/02/16 | آگهی دعوت به مجمع عمومی عادی سالیانه دوره 12 ماهه منتهی به 1403/12/30 |
1403/12/07 | آگهی دعوت به مجمع عمومی فوق العاده دوره 12 ماهه منتهی به 1403/12/30 |
1403/02/18 | آگهی دعوت به مجمع عمومی عادی سالیانه دوره 12 ماهه منتهی به 1402/12/29 |
1402/03/28 | آگهی دعوت به مجمع عمومی عادی سالیانه دوره 12 ماهه منتهی به 1401/12/29 |
1401/04/01 | آگهی دعوت به مجمع عمومی عادی سالیانه دوره 12 ماهه منتهی به 1400/12/29(اصلاحیه) |
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.